Impact BioMedical Inc. (IBO)
NYSEAMERICAN: IBO · Real-Time Price · USD
2.650
+0.140 (5.58%)
At close: Nov 20, 2024, 4:00 PM
2.810
+0.160 (6.04%)
After-hours: Nov 20, 2024, 5:54 PM EST
Impact BioMedical Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | 1.17 | -4.34 | -7.05 | -1.3 | -0.81 | -0.45 | |
| Depreciation & Amortization | 0.01 | 0.01 | - | - | - | - | |
| Other Amortization | 1.11 | 1.11 | 1.11 | 1.11 | - | - | |
| Asset Writedown & Restructuring Costs | - | - | - | - | - | 0.09 | |
| Loss (Gain) From Sale of Investments | - | - | 4.1 | - | - | - | |
| Loss (Gain) on Equity Investments | - | - | - | - | - | 0.04 | |
| Other Operating Activities | -5.73 | -0.07 | -0.83 | -1.94 | -0.08 | -0.2 | |
| Change in Accounts Receivable | - | -0.13 | - | - | - | - | |
| Change in Accounts Payable | 0.53 | 0.29 | 0.42 | 0.11 | 0 | -0.08 | |
| Change in Other Net Operating Assets | -0.17 | 0.27 | -0 | -0 | -0 | -0.01 | |
| Operating Cash Flow | -3.1 | -2.85 | -2.24 | -2.03 | -0.9 | -0.61 | |
| Capital Expenditures | - | -0.02 | -0.28 | - | - | - | |
| Cash Acquisitions | - | - | - | - | - | 0.01 | |
| Investment in Securities | - | - | -0.07 | -4.19 | -0.63 | -0.13 | |
| Other Investing Activities | 0 | 0 | -0.01 | -5.28 | - | - | |
| Investing Cash Flow | 0 | -0.02 | -0.35 | -9.46 | -0.63 | -0.11 | |
| Short-Term Debt Issued | - | 2.87 | 2.55 | 11.46 | 1.06 | - | |
| Total Debt Issued | 1.83 | 2.87 | 2.55 | 11.46 | 1.06 | - | |
| Net Debt Issued (Repaid) | 1.83 | 2.87 | 2.55 | 11.46 | 1.06 | - | |
| Issuance of Common Stock | 3.73 | - | - | - | 0.44 | 0.55 | |
| Other Financing Activities | - | - | - | - | - | 0.25 | |
| Financing Cash Flow | 5.56 | 2.87 | 2.55 | 11.46 | 1.49 | 0.8 | |
| Miscellaneous Cash Flow Adjustments | - | - | - | -0 | - | - | |
| Net Cash Flow | 2.47 | -0 | -0.04 | -0.03 | -0.04 | 0.07 | |
| Free Cash Flow | -3.1 | -2.87 | -2.52 | -2.03 | -0.9 | -0.61 | |
| Free Cash Flow Margin | - | - | -5036.00% | - | - | - | |
| Free Cash Flow Per Share | -0.05 | -0.05 | -0.04 | -0.03 | -0.01 | - | |
| Levered Free Cash Flow | -1.33 | -1.44 | -0.98 | -1.16 | -0.56 | -0.41 | |
| Unlevered Free Cash Flow | -0.75 | -1.17 | -0.69 | -0.97 | -0.56 | -0.41 | |
| Change in Net Working Capital | -0.41 | -0.25 | -0.6 | 0.09 | 0 | 0.08 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.